Impact of CFTR Modulator Therapies on Musculoskeletal Health in Pediatric Cystic Fibrosis
发布者：Unknown
·发布于: 2025-12-13
A discussion seeking current evidence regarding the effects of CFTR modulator therapies, specifically ivacaftor and ETI, on bone mineral density, muscle mass, and strength in children and adolescents with cystic fibrosis.